These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 7120069)

  • 41. Decreased binding of verapamil to plasma proteins in patients with liver disease.
    Giacomini KM; Massoud N; Wong FM; Giacomini JC
    J Cardiovasc Pharmacol; 1984; 6(5):924-8. PubMed ID: 6209501
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Disposition of chlordiazepoxide: sex differences and effects of oral contraceptives.
    Roberts RK; Desmond PV; Wilkinson GR; Schenker S
    Clin Pharmacol Ther; 1979 Jun; 25(6):826-31. PubMed ID: 445949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dose-dependent kinetics of probenecid in rhesus monkeys-intravenous bolus studies.
    Chiang CW; Benet LZ
    Pharmacology; 1981; 23(6):326-36. PubMed ID: 7312942
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of acute viral hepatitis on disposition and plasma binding of tolbutamide.
    Williams RL; Blaschke TF; Meffin PJ; Melmon KL; Rowland M
    Clin Pharmacol Ther; 1977 Mar; 21(3):301-9. PubMed ID: 837649
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of cimetidine on quinidine distribution and tissue pH in rats.
    Shibasaki S; Kawamata Y; Nishigaki R; Umemura K
    J Pharmacobiodyn; 1989 Jun; 12(6):324-31. PubMed ID: 2778625
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of ceftriaxone in liver-transplant recipients.
    Toth A; Abdallah HY; Venkataramanan R; Teperman L; Halsf G; Rabinovitch M; Burckart GJ; Starzl TE
    J Clin Pharmacol; 1991 Aug; 31(8):722-8. PubMed ID: 1880231
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The pharmacokinetics and organ distribution of ajmaline and quindine in the mouse.
    Iven H
    Naunyn Schmiedebergs Arch Pharmacol; 1977 May; 298(1):43-50. PubMed ID: 882146
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of digoxin in patients subjected to the quinidine-digoxin interaction.
    Schenck-Gustafsson K; Dahlqvist R
    Br J Clin Pharmacol; 1981 Feb; 11(2):181-6. PubMed ID: 7213521
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Disposition of valproic acid in man.
    Gugler R; Schell A; Eichelbaum M; Fröscher W; Schulz HU
    Eur J Clin Pharmacol; 1977 Oct; 12(2):125-32. PubMed ID: 336377
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparative pharmacokinetics of quinidine and its O-desmethyl metabolite in rabbits.
    Ueda CT; Nickols JG
    J Pharm Sci; 1980 Dec; 69(12):1400-3. PubMed ID: 7463324
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Pharmacokinetics of prednisone and prednisolone at steady state in the rabbit.
    Unadkat JD; Rowland M
    Drug Metab Dispos; 1985; 13(4):503-9. PubMed ID: 2863117
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lack of effect of smoking on the metabolism and pharmacokinetics of quinidine in patients.
    Edwards DJ; Axelson JE; Visco JP; vanEvery S; Slaughter RL; Lalka D
    Br J Clin Pharmacol; 1987 Mar; 23(3):351-4. PubMed ID: 3567051
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Decreased quinidine plasma protein binding during hemodialysis.
    Kessler KM; Perez GO
    Clin Pharmacol Ther; 1981 Jul; 30(1):121-6. PubMed ID: 7237891
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics, metabolism, and disposition of 6-chloro-2,3,4,5-tetrahydro-3-methyl-1H-3-benzazepine (SK&F 86466) in rats and dogs.
    Gombar CT; Straub K; Levandoski P; Gutzait L; Swagzdis J; Garvie C; Joseph G; Potts BD; Mico BA
    Drug Metab Dispos; 1986; 14(5):540-8. PubMed ID: 2876859
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics and pharmacodynamics of quinidine and its metabolite, quinidine-N-oxide, in beagle dogs.
    Rakhit A; Guentert TW; Holford NH; Verhoeven J; Riegelman S
    Eur J Drug Metab Pharmacokinet; 1984; 9(4):315-24. PubMed ID: 6532805
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative disposition kinetics of two diastereomeric pairs of cinchona alkaloids in the dog.
    Abraham I; Ueda CT
    J Pharm Sci; 1984 Apr; 73(4):452-6. PubMed ID: 6726627
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Elimination kinetic of high polar metabolites pool of quinidine from human serum.
    Camsonne R; Moulin MA; Charbonneau P; Bazin C
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):74-5. PubMed ID: 3988396
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assessment of quinidine gluconate for nonlinear kinetics following chronic dosing.
    Russo J; Russo ME; Smith RA; Pershing LK
    J Clin Pharmacol; 1982; 22(5-6):264-70. PubMed ID: 7107973
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acebutolol disposition after intravenous administration.
    Meffin PJ; Winkle RA; Peters FA; Harrison DC
    Clin Pharmacol Ther; 1977 Nov; 22(5 Pt 1):557-67. PubMed ID: 913023
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Quinidine as a probe for CYP3A4 activity: intrasubject variability and lack of correlation with probe-based assays for CYP1A2, CYP2C9, CYP2C19, and CYP2D6.
    Damkier P; Brøsen K
    Clin Pharmacol Ther; 2000 Aug; 68(2):199-209. PubMed ID: 10976551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.